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Abstract
Background: Coronary artery disease has a significant disease burden, but there are many known barriers to
management of acute coronary syndrome (ACS). General practitioners (GPs) bear considerable responsibility
for post-discharge management of ACS in Australia and New Zealand (NZ), but knowledge about the extent
and efficacy of such management is limited. This systematic review summarises published evidence from
Australia and New Zealand regarding management in primary care after discharge following ACS.
Methods: A search of PubMed, Scopus, CINAHL-Plus and PSYCINFO databases in August 2015 was supplemented by
citation screening and hand-searching. Literature was selected based on specified criteria, and assessed for quality
using the Mixed Methods Appraisal Tool (MMAT). Extracted data was related to evidence-based interventions specified
by published guidelines.
Results: The search yielded 19 publications, most of which reported on quantitative and observational studies from
Australia. The majority of studies scored at least 75 % on the MMAT. Diverse aspects of management by GPs
are presented according to categories of evidence-based guidelines. Data suggests that GPs are more likely to
prescribe ACS medications than to assist in lifestyle or psychological management. GP referral to cardiac
rehabilitation varied, and one study showed an improvement in the number of ACS patients with documented ACS
management plans. Few studies described successful interventions to improve GP management, though some quality
improvement efforts through education and integration of care with hospitals were beneficial. Limited data was
published about interventions effective in rural, minority, and Indigenous populations.
Conclusions: Research reflects room for improvement in GP post-discharge ACS management, but little is known
about effective methods for improvement. Additional research, both observational and interventional, would assist GPs
in improving the quality of post-discharge ACS care.
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Background
Modern medical treatments like coronary revasculariza-
tion for acute coronary events have benefits of high rates
of patient recovery but there are high risks of hospital
readmission and mortality for survivors. For example, a
recent follow up of patients undergoing percutaneous
coronary interventions found that 4.7 % were readmitted
within 30 days, and nearly half of these (2.1 %) were
classified as ACS/heart failure related [1]. For this rea-
son, it is imperative that patients receive proper medical
management of coronary risk factors and support for the
adoption of a healthy lifestyle [2–4].
Based upon good evidence, guidelines recommend
comprehensive post-discharge ACS care that covers
management of biomedical and lifestyle risk factors,
pharmacotherapy, psychological factor assessment, and
assistance in initiating and maintaining behaviour change
[5, 6] (Table 1). Interventions recommended by the guide-
lines are known to reduce patients’ risk of subsequent car-
diac events [5, 7–9]. However, since hospital stays for ACS
are decreasing in length, much of the responsibility for
post-discharge management is left to the general practi-
tioner (GP).
The implementation of recommended interventions is
imperfect [10, 11] as there are many barriers and facili-
tators to post-discharge management of CVD. ACS is
usually treated in-hospital, and so primary care manage-
ment depends on the receipt of informative discharge
summaries from medical specialists. Additionally, comor-
bidities like diabetes and depression often make ACS
management in primary care more complicated [12].
Adherence to these evidence-based guidelines has
been shown to vary in different populations [13].
Australia and New Zealand’s populations enjoy compar-
able health status and both have universal public health
coverage [14, 15]. In both these nations, coronary artery
disease is a top health system priority. In Australia, cor-
onary heart disease is responsible for over 10,000 deaths
every year, and this number is expected to reach 13,675
by the year 2020 [16]. However, several factors compli-
cate ACS management in these nations, with both
Australia and New Zealand’s health systems having large
rural populations. This may require patients to travel
considerable distances to access health services like
cardiac rehabilitation (CR), and there are known chal-
lenges around integration of hospital and primary care
management in rural areas. In addition, both nations have
significant Indigenous populations that carry a dispropor-
tionate burden of CVD [17, 18] with poorer socioeco-
nomic circumstances compared to non-Indigenous people
[19]. Both Australia and New Zealand’s health systems
have funding complexity for health services [14, 15] des-
pite significant government funding to support access to
healthcare for citizens.
Studies that attempt to document ACS management
often focus on particular aspects like drug utilization
[20, 21] and CR referral and attendance [22]. However,
little is known about overall general practice manage-
ment of ACS, especially in the context of the health sys-
tems of Australia and New Zealand. Syntheses of
primary care research have been shown to be useful in
shaping health policy initiatives [23]. This study aims to
synthesize, using a systematic approach, knowledge
about evidence-based post-discharge treatment of ACS
in primary care settings in Australia and New Zealand.
Methods
Information sources and search strategy
A systematic literature search was conducted using the
following electronic databases: PubMed, SCOPUS, Psy-
chINFO and CINAHL. The search terms comprised sub-
ject headings specific to databases where applicable,
such as Medical Subject Headings (MeSH) in PubMed,
as well as synonyms for these terms generated by the au-
thors or listed in the databases. These searches were
supplemented by citation screening of retrieved records
and additional hand searching.
Records retrieved were those containing search terms
related to ACS, patient discharge/post-discharge man-
agement, and either primary care, secondary prevention,
and/or cardiac rehabilitation (CR). CR was included as a
domain in the search strings because, although generally
Table 1 Evidence-based interventions for acute coronary
syndrome in primary care [5, 6]
















Psychological Management Depression management
Social Support
Behaviour Change Referral to cardiac rehabilitation
Chest pain action plan
ACEi/ARB angiotensin-converting enzyme inhibitor/angiotensin-II
receptor blocker
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defined as medically supervised programs, CR services are
sometimes expanded to include many different aspects of
post-discharge management of ACS [24]. The literature
search was limited to studies conducted in Australia or
New Zealand and to journal articles published in the
English language from the year 2000 onwards.
The literature search was last conducted on August
18th, 2015. An example of a search string is presented in
Additional file 1.
Study selection and inclusion criteria
Duplicates were identified and removed. The remaining
titles and abstracts were screened for eligibility and
those that did not meet the inclusion criteria (Table 2)
were excluded. Two reviewers (JW and MB) conducted
this initial screening process independently, with any
discrepancies resolved by discussion. Full-texts of the
remaining publications were retrieved and assessed by
three authors (MB, MD, JW) against the inclusion and
exclusion criteria. A flow diagram of the literature search
and selection process is presented in Fig. 1.
Data extraction and appraisal
Data extraction was undertaken by all authors utilising a
template with studies grouped according to the type of
evidence-based primary care intervention they described.
Studies were assessed for quality by one author (MB)
based on the Mixed Methods Appraisal Tool (MMAT)
[25], a method of appraising studies of various designs,
in consultation with a second author (JW).
Results
Of a total of 219 publications identified, 76 underwent full
review and 19 publications reporting on 17 studies met
the inclusion criteria (Fig. 1). Most studies were Australian
(n = 15), quantitative (n = 16), and observational (n = 16).
Only one randomized controlled trial was identified and
there was only one qualitative study. Few studies exam-
ined Indigenous (n = 3), other non-Indigenous minority,
or rural (n = 5) populations. Two studies examined exclu-
sively female populations, and most studies were con-
structed with patients (n = 15) rather than GPs (n = 4) as
study populations. A description of studies is presented in
Table 3. Studies that reported including male and female
populations consistently included a majority of male par-
ticipants (n = 12).
Many publications reported studies on efforts to
improve patient follow-up care that were directed
from hospitals where patients with ACS had been
treated, and these contained limited information re-
garding specific primary care involvement. Findings
are reported in Table 4 and below, categorised ac-
cording to areas of evidence-based management spe-
cified by the Cardiac Society of Australia and New
Zealand (CSANZ) guidelines [2].
Pharmacotherapy
Six studies explored various aspects of pharmaco-
logical management of ACS in primary care. One recent
Australian observational study reported outcomes of pa-
tients (n = 12813) following a percutaneous coronary
Table 2 Literature screening (PICO) criteria
Inclusion Exclusion
Population (P) -ACS patients
-GPs treating patients post-ACS
-Studies conducted in Australia or New Zealand




-Non-acute coronary artery disease
-Other acute illnesses





-Aspects of evidence-based management not
undertaken in a primary care setting
Comparator (C) (not applicable) (not applicable)
Outcome (O) -Clinical indicators of care, including:
-Medication prescription rates including LLT
-Smoking cessation/advice rates
- Lifestyle advice receipt
-CR referral rates
-Depression, anxiety, stress rates
-Rates of psychological assessment
-Dietary advice rates
-Insights about barriers and facilitators to primary care management
-Comparisons of efficacy of pharmaceuticals
-Indicators measured in hospital or at discharge
-Indicators in pre-hospital care








ACS acute coronary syndrome, GP general practitioner, LLT lipid-lowering therapy, CR cardiac rehabilitation
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intervention (PCI), the majority in the context of ACS
[26]. In 2010, 75 % of patients were taking ≥ 4 classes of
drugs at 12 month follow-up. The study also analysed
trend data from 2005 to 2010 and found an increase over
time in receipt of all drug classes investigated (p < 0.01).
Finally, the same study found that females and patients
aged > 75 years had significantly lower rates of medication
usage than males and younger patients. Medication use
was determined either by patient report or record review.
An observational study conducted in New Zealand [27]
reported similar rates of medication use at 3-year fol-
low-up (n = 112). However, another New Zealand study
reported lower rates of medication use in a cohort of cor-
onary artery bypass grafting (CABG) patients (n = 109) at
three-year follow-up [28]. Wachtel et al. [29] conducted a
retrospective analysis of hospital and GP medical records
(n = 34 patients), and found that GPs generally increased
the prescription of evidence-based medications compared
to prescription rates at hospital discharge.
Two interventional studies used medication prescrip-
tion rates at GP follow-up as a clinical indicator to
evaluate programs designed to improve post-ACS care
[30, 31]. Hickey et al. [30] examined a quality improve-
ment initiative known as the Brisbane Cardiac Consor-
tium (BCC). The intervention included recurrent GP
performance feedback from researchers in addition to
GP liaison with hospitals regarding patient management.
Though the study showed significant improvements in
some clinical indicators, it did not report a significant
change in prescription rates of medications in primary
care follow-up post-intervention (n = 89 and n = 104 for
3- and 6- month follow-up, respectively). Scott et al. [31]
examined the efficacy of a multi-faceted intervention
that included clinical decision support, educational in-
terventions, regular performance feedback, patient
self-management strategies, and hospital-community
integration. The study found greater prescription rates
of aspirin at 3 months post-discharge in intervention
Fig. 1 Flowchart of Search Strategy and Output: PRISMA flowchart
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Table 3 Included studies of primary care post-discharge management of acute coronary syndrome
First Author (Year) Study Design Location Participants Evidence-Based Intervention(s)
(per NHF/CSANZ Guidelines [5])
Cole (2014) [26] Cohort Melbourne, Australia 12,813 PCI patients in the Melbourne
Intervention Group registry
Pharmacological management
Fernandez (2006) [38] Cross-Sectional: consecutive
case series




Ford (2011) [27] Cohort with 3 year follow up Auckland, NZ 112 ACS patients Lifestyle management
Pharmacological management
Gallagher (2003) [35] Cohort; Mixed Methods Sydney, Australia 196 female CR participants Behaviour change
Hansen (2011) [43] Qualitative Tasmania, Australia 35 ACS patients who were smokers
at time of hospitalisation
Lifestyle management
Hickey (2004) [30] Cross-Sectional: indicators of care Brisbane, Australia 104 ACS patients Lifestyle management
Pharmacological management
Johnson (2010) [42] Retrospective analysis of registry
data combined with (self-report) survey
Hunter, Australia 4971 patients eligible for CR Lifestyle management
Looi (2011) [28] Retrospective cohort, data from
hospital CCU database
Auckland, NZ 129 of 901 patients with ACS who
received inpatient CABG
Pharmacological management
Mudge (2001) [33] Retrospective cohort Brisbane, Australia 282 of 352 ACS patients with follow-
up information available
Pharmacological management
Biomedical risk factor management
Reddy (2008) [39] (further details in [48]) Descriptive short report of an intervention
using mixed methods
Victoria and South Australia 36 health professionals Psychological management
Rushford (2007) [36] Cross-Sectional; Mixed Methods Melbourne, Australia 224 female ACS patients Behaviour change
Schrader (2005) [41] RCT Adelaide, Australia 669 cardiac patients Psychological management
Schulz (2000) [37] Cross-Sectional: follow-up survey Horsham, Australia 79 MI patients Behaviour change
Scott (2004) [31] Before-after evaluation of a quality
improvement program of in-hospital &
post-discharge care for cardiac patients
(ACS or HF)
Brisbane, Australia 344 ACS patients (of 662 eligible)
who had evaluable follow-up data
Behaviour change
Pharmacological management
Toms (2003) [34] Cross-Sectional Canberra, Australia 93 MI patients Behaviour change
Pharmacological management
Lifestyle management
a. Wachtel (2008) [29]
b. Wachtel (2008) [40]
Retrospective cohort: analyses of hospital
records & follow-up in GP clinics
Riverland, Australia 34 MI patients with GP records,




a. Peterson (2012) [32]
b. Wai (2012) [20]
Before-after evaluation of a quality
improvement program discharge
care (ACS)
Australia Pre: 49 hospitals; 1545 ACS patients
recruited
Post: 45 hospitals remained in
program; 1589 ACS patients recruited
Behaviour change
Pharmacological management
ACS acute coronary syndrome, CABG coronary artery bypass grafting, CCU coronary care unit, CR cardiac rehabilitation, HF heart failure, MI myocardial infarction, NZ New Zealand, PCI percutaneous coronary














Table 4 Key findings on primary care post-discharge management of acute coronary syndrome
First Author (Year)
Aim or Research question
Key findings on ACS interventions
in primary care
Principal conclusions Study Quality Comments
MMAT Score
Cole (2014) [26] Significant increase (p < 0.01) in
frequency of use of all EBM
investigated during calendar period
2005–2010









has increased over the 6-year study
period, but treatment gap remains
• Data extracted from pre-existing ACS
follow-up registry
• 89 % follow-up
MMAT: 100 %
Fernandez (2006) [38]
To investigate risk factor status
of post-PCI patients
Risk factor status at 1 year post-PCI:
Systolic blood pressure above target 31 %
Total cholesterol above target 58 %
Smoking 15 %
BMI above healthy range 77 %
Obesity 34 %
Physical activity below target 48 %
Depression & anxiety 25 %
One third of patients erroneously
believed that they had no heart problems
There is inadequate management of
identifiable risk factors among post-PCI
patients 12–18 months after
revascularisation
• 39 % response among eligible
participants




To measure attainment of New
Zealand Guideline Group targets
& highlight areas of weakness
Risk factor status at 3 years post-ACS (2010):
Attainment of target blood pressure 76 %
Smokers who quit 52 %
BMI in target range 24 %
HDL levels above target 74 %
LDL levels below target 52 %
In 2010, at 3 years post-ACS, % of





GTN spray 27 %
Concern that GPs were using
outdated guidelines
Mixed achievement of NZGG
program—large treatment gaps for
BMI, HbA1c & lifestyle





Reports data by ethnicity
Survivorship bias (26 patients had died)




To identify determinants of
women’s attendance at CR and
adherence to risk factor modification
At 12 weeks post-discharge:
• Two-thirds of women referred to CR
• Only one third of the total sample
attended CR
• CABG patients more likely to be referred
than MI patients
• Lack of employment, age <55 or >70
and stressful personal life event decreased
the odds of attending
Good adherence to guidelines on
medications, stress modification &
smoking


















Table 4 Key findings on primary care post-discharge management of acute coronary syndrome (Continued)
Hansen (2011) [43]
To investigate experiences of
ongoing smoking or smoking
cessation post-ACS
In 2006–2008, insights about GP smoking
advice to patients post-ACS:
• GP advice sometimes resented and
sometimes appreciated
• GPs more likely to talk to than lecture at
patients compared to specialists
• Doctor patient rapport is important
• Majority of quitters spontaneously quit
with no GP advice
• Failed quitting attempts lead to
hopelessness
Being bombarded with anti-smoking
advice during hospitalisation can
result in patients “turning off”
Anti-smoking advice may have a
positive cumulative effect when
presented well & at the right time
Pharmacotherapy is underutilised
GPs could better inform patients
about the process of quitting &
available supports
• Appropriate subject selection
• Low dropout
• No comments on how researchers
could influence interview responses
MMAT: 75 %
Hickey (2004) [30]
To determine whether reliable and
valid clinical indicators could
measure ACS primary and hospital
care
To determine whether education
efforts could improve these clinical
indicators
In 2002, insights from a program for
hospitals and GPs:
• Robust process and outcome clinical
indicators can be developed to assess
primary and hospital care that are relevant,
reliable, valid and high impact
• Education program improved 17/40
developed indicators
Suboptimal performance was improved
with feedback to GPs.
Economical data collection and timely
feedback would improve QI process
Sustainability of this approach limited
by expense and labour
• Listed strategies for minimization of
measurement error




To determine whether self-reported
receipt of lifestyle advice from a
health care provider is lower among
outpatient cardiac rehabilitation
(OCR) non-attendees and non-referred
patients compared to OCR attendees
In 2002–2007, % of patients receiving lifestyle
advice from GPs:
Advised to increase physical activity 71 %
Advised to follow a modified fat diet 55 %
Advised to quit smoking out of patients
who smoked in last 6 months 88 %
Recommended that referred patients
who do not attend CR be identified
by their GP and encouraged to
participate in home-based CR
• 65 % consented to inclusion
• Consenters more likely to be male and
undergo CABG
• Analysis based on self-report: patient
recall 5 months post-discharge
• Large sample size: used Hunter New
England Heart and Stroke Registry
• Potential response bias
• May underestimate appropriate advice
• Considerable missing data
MMAT: 100 %
Looi (2011) [28]
To measure adherence to evidence-
based ACS medications post-CABG
In 2006–2007, at 3 years post-CABG, % of





Major adverse cardiological events
(6.2 %/year): 3 UA, 4 NSTEMI, 6 HF, 5 deaths
Secondary prevention medication
usage in ACS patients undergoing
CABG was disappointingly low at
discharge and worse at follow-up
• 86 % response rate
• Association between cardiac events and




To measure prescription of lipid-
lowering drugs on discharge, and
patient adherence at follow up
In 1998–1999, at 6–18 months post-ACS,
patient status in lipid management:
Did not have lipid measurements 10 %
Of patients not prescribed LLD at discharge,
patients who did not receive LLD prescription
from GP 70 %
Of those prescribed LLD on discharge,
patients who remained on the treatment




community interface, poor ongoing
monitoring and dosage adjustment
• No inferential statistics reported
• Follow-up information incomplete
















Table 4 Key findings on primary care post-discharge management of acute coronary syndrome (Continued)
Reddy (2008) [39]
To assess the extent to which
evidence-based guidelines have
influenced medical practice with
respect to their experiences in
depression assessment and
management
Insights from surveys and interviews with GPs:
• Little consistency among health professionals
on how best to identify and manage depression
• Few GPs asked patients about depression,
regardless of patients’ depression score
• Wide distribution of guideline-related
information was not effective in
improving depression management
• No agreement on appropriate time
and provider for depression screening
• Published short report provides little
detail regarding study design
and quality appraisal
• Study time frame not reported
MMAT: n/a
Rushford (2007) [36]
To assess patient recall of risk factor
behaviour modifying intervention at
discharge, 2, 4 and 12 months
Insights from study at 12 month follow-up:
• CR referral is correlated with attendance
• 8 % of women reported wanting more
lifestyle advice
Limited advice provided on lifestyle
(especially on diet & physical activity)
to women who were obese or inactive.
Older women less likely to recall
receiving information
Health staff need training in information
delivery and communication skills
• Response rate 79 %
• Good reasons for exclusion
• Detailed assessment of recall on many
areas of lifestyle
• No details on how the initial patient
education was conducted or its content
MMAT: 100 %
Schrader (2005) [41]
To evaluate the effect on depressive
symptoms in cardiac patients of
patient-specific advice to general
practitioners regarding management
of comorbid depression
In 2000–2001, in a randomized controlled trial:
• The intervention had little effect on
moderate to severe depression at 12 months
• Telephone call to GP from psychiatrist led
to a significant decrease in proportion of
patients with moderate to severe depression
• Multidisciplinary enhanced Primary Care
case conference not effective (and difficult
to implement)
Recommended screening of hospitalised
cardiac patients for depression ansd
providing targeted advice to their GPs
• No information on what management
plans were actually delivered by GPs and
no information on antidepressant
prescription and service utilisation
• Follow-up below 80 % (78.5 %) with
differential non-reponse in younger
separated/divorced patients and smokers
• Allocation concealment unclear
MMAT: 50 %
Schulz (2000) [37]
To identify factors associated with
and predicting attendance of post-
MI patients at CR program
In 1993–1996, ~3.5 years post-MI:
• 73.4 % referred to CR
• Majority (72 %) of non-attenders were not
referred to CR
• Non-referral was significantly associated
with non-attendance
• Attendance significantly associated with referral
Being older, living farther away, living
alone and not having private transport
wre associated with CR non-attendance
Referral to CR also predicted attendance
• 69 % response rate
• Strengths and limitations of study well
identified
• Have not defined completion other than
to offer second dropout rate of 36 % if
attended 6 or fewer sessions
MMAT: 75 %
Scott (2004) [31]
To optimise care of patients with
ACS and CHF through a QI intervention
across two sectors (hospital and GP)
of healthcare
In 2000–2002, at 3 months post-ACS, % of
medications prescribed to patients:
Aspirin: (baseline) 82 % (intervention) 89 %
Aspirin continuation in those prescribed at
discharge: (baseline) 84 % (intervention) 92 %
βB continuation among those prescribed at
discharge: (baseline) 76 % (intervention) 85 %
Implementing systems of decision
support, targeted provider education
& performance feedback, patient self-
management and hospital-community
integration improved patient care,
particularly when directly controlled
by individual clinicians (e.g., prescribing)
• Not possible to attribute specific process-
of-care changes to specific QI initiatives
within a multifaceted program
• Only significant results reported
MMAT: 50 %
Toms (2003) [34]
To determine whether Phase II
outpatient CR participants are more
successful at achieving cardiac risk
factor targets than non-participants
at follow-up post-MI
In 2003, at 18–36 months post-MI:
• Of 36 included CR non-participants (NP),
53 % not referred by doctor
• CR participants less likely to have total
cholesterol > 6.5 mmol/L
• Fewer non-participants were receiving
cholesterol lowering medication
• In both groups, approximately 50 % did not
achieve target total cholesterol (≤4.5 mmol/L)
• CR participants more likely to be on lipid
modifying treatment
• More CR participants exercised regularly
Those attending CR had better long
term outcomes, exercising more and
more achieving the goal of a
TC ≤6.5 mmol/l
• Participants resided within 40 km of
Canberra therefore geography less of
an issue
• Used TC to assess lipids, not LDL
• Highlight need for data collection
• Low response rate (51 %)
• Limitations of study recognised















Table 4 Key findings on primary care post-discharge management of acute coronary syndrome (Continued)
• Failure to achieve blood pressure and
weight control similar in both groups
• Small numbers continued smoking in
both groups but insufficient sample size to
assess statistical significance
• More CR participants had returned to work
(92 % vs. 78 %) but not statistically significant
even after adjusting for age
a. Wachtel (2008) [29]
b. Wachtel (2008) [40]
To determine assessment of lifestyle
and behavioural risk factors in post-MI
patients in hospital and at GP follow-
up in a rural region of South Australia
In 2004–2005:
• Population was 78 % male
• One Aboriginal/Torres Strait Islander patient (2 %)
• Majority of patients did not receive an
intervention for risk factors
• 5/11 (45 %) patient smokers received quit
advice, one prescribed NRT
• Higher proportion of patients received
lifestyle interventions in GP practice than
hospital setting, however, with the exception
of smoking this accounted for 7 % of patients
• 16/34 (47 %) patients had BMI assessed
• 11 were overweight/obese of whom 2
(18 %) received weight loss advice
GPs generally increased prescribing
of evidence based medications from
time of discharge
Major gap in CR and secondary
prevention management of ACS
patients in rural South Australia
• No documentation of special/additional
services for ATSI population
• Lifestyle and behavioural risk poorly
documented except smoking status (76 %)
and hypertension and diabetes (82 %
and 78 %)
• Low response rate
MMAT: 50 %
a. Wai (2012) [20]
b. Peterson (2012) [32]
To improve the management of ACS
at the point of hospital discharge,
across the continuum of care
In 2009, at a median of 96-day- follow-up
(range 49–204):
• 48 % reported using 4 evidence-based
medications (EBMs), with a significant
decrease in anti-platelet agents, statins, β
blockers and all 4 EBMs
• 67 % recalled referral to CR of whom 33 %
completed CR and 21 % were still attending CR
• 731 GPs (47 % of patient-nominated GPs)
participated in survey
• 77 % received a discharge summary for
patients with ACS at a median time of 3
days (0–41 days) after discharge
• Of these 88 % contained a list of prescribed
medications; 81 % included dose titration
and duration of therapy and 55 % contained
details of ongoing risk management
• 65 % of GPs rated the quality of information
as ‘very good’ to ‘excellent’
• 6 % increase in communication of ACS
management plan to GP
• 18 % increase in patients with documentated
chest pain action plan
Targeted educational intervention can
improve management of patients post-ACS
Improvements evident in:
• Evidence based prescribing
• Communication between patient/carer 7 GP
• Referrals to CR
• Accuracy of sample representation not
documented
• Based on medical record documentation
and GP survey
• Potential for Hawthorne effect
• Low response rate of eligible GPs
MMAT: 75 %
ACEi/ARB angiotensin-converting enzyme inhibitor/angiotensin-II receptor blocker, ACS acute coronary syndrome, βB beta-blockers, BMI body mass index, CABG coronary artery bypass grafting, CR cardiac rehabilitation,
DAPT dual antiplatelet therapy, EBM evidence-based medication, GP general practitioner, GTN glycerol trinitrate, HDL high-density lipoprotein, LDL low-density lipoprotein, LLD lipid-lowering drugs, MMAT Mixed















patients compared to patients that received usual care
(p = 0.05), and high rates of aspirin (p = 0.03) and β-
blocker (p = 0.05) continuation among those pre-
scribed these medications at discharge (n = 344). The
intervention described in Scott et al. [31] also re-
ceived generally positive feedback from patients.
In addition, Wai et al. [20] reported baseline results of
medication use across Australia before a quality im-
provement initiative. This study reported that only 48 %
of patients used four or more evidence-based drugs at a
median of 96-day follow-up (n = 1319). When medica-
tion was stopped post-discharge, “the GP stopped it”
was a major reason cited for discontinuation. The subse-
quent study to these baseline findings [32] did not report
any medication usage rates in follow-up.
Two studies examined rates of lipid-lowering therapy
(LLT) use in primary care follow-up. Mudge et al. [33]
found that 66 % of post-ACS patients were on LLT 6–18
months post-discharge, and that 18 % of post-ACS pa-
tients with cholesterol levels over target did not receive
LLT (n = 282). Toms et al. [34] measured a 50 % LLT
prescription rate 18–36 months post-discharge, and that
more than 50 % of study participants had total serum
cholesterol levels above target (n = 93).
Behaviour change
Five studies described behaviour change related to ACS
in primary care. Gallagher et al. [35] studied an all-
female population to determine predictors of completion
of CR (n = 196). This descriptive study surveyed patients
12 weeks post-discharge, and found that two-thirds of
women were referred to CR, and that CABG patients
were more likely to be referred to CR than were myocar-
dial infarction (MI) patients (though statistical analysis
was not provided).
Rushford et al. [36] examined Australian female ACS
patients and reported that recall by patients of CR refer-
ral by physicians, physiotherapists, nurse practitioners,
or dietitians was correlated with attendance (p = 0.001)
in this cohort (n = 212). Schulz et al. [37] found CR re-
ferral to be the single biggest influencer of attendance,
and also found that being younger (p = 0.032) or married
(p = 0.03) or living with a partner (p = 0.05) made pa-
tients more likely to be referred to CR (n = 79). Gender
was not determined by this study to be a factor influen-
cing CR attendance. Toms et al. [34] compared CR par-
ticipants with non-participants in a observational study,
and found that non-participants cited non-referral most
commonly as the reason for their non-attendance, and
that younger patients were more likely to be participate
in CR. In results from a 2012 Australia-wide quality im-
provement study [32], both GPs and patients reported a
6 % increase in CR referral by GPs post-educational
intervention (n = 636, p-values = 0.05 and 0.001 for GPs
and patients, respectively).
The same interventional study examined the effect of
an education intervention across the continuum of care
on patients’ possession of an ACS management plan
[32], which is an evidence-based guideline recommended
for all post-ACS patients [5]. Compared to baseline,
Peterson et al. [32] found that more patients had docu-
mented ACS management plans (n = 1589, p = 0.01), and
of these, more plans contained a chest pain action
plan (n = 1383, p < 0.0001). This intervention also in-
creased communication of this management plan to
the GP (n = 1589, p = 0.0001).
Psychological assessment
Psychological management in primary care was described
in four studies. Fernandez et al. [38] described significant
levels of depression, anxiety and documented stress in an
observational study of patients 12–18 months after a per-
cutaneous coronary intervention (PCI) (n = 202). Reddy et
al. [39] described a lack of consistency in GP adherence to
a protocol regarding depression screening, and that in a
study of GPs, “about half” of the GPs were prepared to
prescribe antidepressants (n = 18). In this same study, few
GPs asked patients about depression, despite having re-
ceived information about their patient’s depression score.
Wachtel et al. [40] found that no ACS patients received
any relevant behavioural interventions by a GP (n = 55),
and no ACS patients received a social support or living
condition intervention by a GP (n = 45). A rando-
mised controlled trial conducted by Schrader et al.
[41] documented that a GP intervention involving a
telephone consult with a psychiatrist was the most ef-
fective psychological intervention and resulted in a re-
duced relative risk of having moderate to severe
depression (n-237, 95 % CI). The same study found
that non-consent to study procedures was associated
with being older (p < 0.001) and female (p < 0.001).
Lifestyle management
Seven studies discussed management of lifestyle and
behavioural risk factors. Fernandez et al. [38] docu-
mented that 46 % of female and 25 % of male pa-
tients had two or more modifiable risk factors one
year after a PCI (n = 202). The same study found that
patients underestimated their possession of risk fac-
tors: for both hypertension and hypercholesterolaemia,
the portion of patients that reported these conditions
were 9 % and 40 % lower than the portion of patients
who had blood pressure and total cholesterol levels
above target, respectively [38].
One study in Canberra reported that 12 % of CR par-
ticipants, 53 % of CR non-participants, and 28 % of all
studied patients still smoked 18–36 months after an MI
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(n = 93) [34]. Another observational study in Sydney [38]
reported that 15 % of PCI patients were active smokers
at 12- to 18- month follow-up post-PCI. A cross-
sectional study in Auckland (n = 202) [27], found that
52 % of smokers had quit 3 years post-discharge from an
ACS after an implicit intervention by the GP, resulting
in an 11 % decrease in smoking in the study population.
A cohort study conducted by Wachtel et al. [29] re-
ported that 45 % of patients received a smoking interven-
tion in their GP clinics, while none received this
intervention in the hospital setting (n = 34). A larger
cross-sectional study [42] found that 88 % of post-ACS
smokers received advice to quit (n = 674). One cross-
sectional study [30] reported a significant improvement of
smoking cessation at 3- and 6- month post- ACS event
(n = 89 and n = 104, respectively) after a quality im-
provement program which included an education inter-
vention targeting hospitals and GPs (p ≤ 0.05 for both).
A qualitative study [43] which described how Austra-
lian smokers and ex-smokers viewed the role of their
GPs post-ACS found that many of the participants
expressed a negative reaction to GP advice about smok-
ing cessation, especially when it was unsolicited (n = 41).
Some participants expressed that smoking advice was
hard to receive when they were unwell or frightened. Pa-
tients in the study expressed feeling distressed when
GPs attributed all their health problems to smoking, and
some admitted to lying to their GP about quitting. Par-
ticipants often described the manner in which GPs
spoke to them about smoking cessation as significant:
doctors who had quit smoking or had personal experi-
ences with smoking were more likely to be persuasive.
Other studies described management of physical activity
in primary care. The observational study conducted by
Fernandez et al. [38] documented that 12 % of patients
performed no physical activity 12–18 months after a PCI
(n = 202), while the Toms et al. study [34] found that 65 %
of MI patients exercised less than 3 times a week 18–36
months post-MI (n = 93). Ford et al. [27] found that in
New Zealand, 47 % patients exercised 4 or more times a
week 3 years after their ACS event (n = 112). Johnson et
al. [42] reported that 76 % of patients were told to increase
physical activity by a primary care professional (n = 4330),
while another study [40] found that only 3 % of patients
had an intervention in their GP clinic regarding physical
activity (n = 34).
Fernandez et al. [38] reported 18 % of patients had
hypercholesterolaemia 12–18 months after a PCI (n = 200).
A cross-sectional study [27] showed a 0.8 mmol/L de-
crease in total cholesterol levels 3 years after ACS dis-
charge (P < 0.001) compared to pre-PCI values (n = 112).
One study found that 60 % of patients received advice in a
primary care setting to follow a modified fat diet (n = 4347)
[42] while another found that only 6 % of patients (n = 34)
reported receiving advice regarding their dietary
habits in a GP clinic [40]. The same study also de-
scribes that 7 % (n = 29) of patients reported receiving
a GP intervention about being obese or overweight,
while 3 % (n = 33) reported receiving an intervention
for alcohol intake.
Besides the four categories outlined by the National
Heart Foundation of Australia (NHFA), one study also
examined hospital communication as a barrier to pri-
mary care management of ACS. As reported by Wai et
al. [20], only 77 % of GPs (n = 731) reported receiving
discharge summaries of ACS patients from hospitals at
baseline. In addition, not all discharge summaries in-
cluded prescribed medications (88 %) and risk factor
management details (55 %). Only 65 % participating in
the GP survey considered the quality of hospital infor-
mation provided as “very good” or “excellent”. A subse-
quent educational intervention did not significantly
improve the quality of these discharge summaries [32].
Discussion
Though adherence to post-ACS management guidelines
varied across studies, it is clear that there is much room
for improvement in optimising follow-up care following
discharge after an acute cardiac event. Reducing morbid-
ity and mortality through adequate secondary prevention
would also be financially prudent as it would reduce
costs to the health care system. De Guyter and col-
leagues undertook a cost benefit analysis over a 10 year
period which estimated substantial economic and social
impacts of increasing the uptake of cardiac rehabilitation
and secondary prevention [44]. Compared with a base
case of 30 % uptake, increasing uptake of CR to 50 %
(scenario 1) or 65 % (scenario 2) gave a benefit cost ratio
of 5.6 and 6.8 which translated to net financial savings of
$46.7 million (scenario 1) and $86.7 million (scenario 2)
and a reduction in Disability Adjusted Life Years of
21,117 to 37,565 compared with the base. Given the pre-
eminent role of primary health care in supporting pa-
tient care outside of the hospital, this component of the
health care system has a role in secondary prevention
that is essential to improving outcomes following coron-
ary events and in minimising unnecessary health care
costs, and hence the need to examine how well this is
being undertaken.
Knowledge of post-ACS GP management
This review is unique in its summary of the knowledge
base of primary care of coronary artery disease post-ACS
in Australia and New Zealand. The 19 peer-reviewed pub-
lications show there is fragmented understanding of post-
ACS care by GPs in Australia and New Zealand. Since the
studies are diverse in study design, quality, analytical
methods, setting, and time frame, it is difficult to discern
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any emerging patterns. However, some strengths and
weaknesses do arise.
Studies of medication prescription rates post-ACS re-
port mostly high rates of antiplatelet therapy prescription
[20, 26, 27, 31], with one study reporting an encouraging
positive trend in medication prescription over time [26].
However, the prescription rates of other evidence-based
medications demonstrate room for improvement, espe-
cially angiotensin-converting enzyme inhibitor/angioten-
sin-II receptor blockers (ACEi/ARBs) and glycerol
trinitrate (GTN) spray [27, 28]. Out of two interventional
studies aiming to improve medication prescription rates,
only one reported a significant positive impact [31]. The
limited number and success of interventional studies and
the diverse range of medication prescription rates (as de-
scribed in Table 3) highlight the need for further research
in ways to improve medication prescription by GPs in pri-
mary care.
Studies examining CR paid little attention to the role
of GPs in influencing CR attendance: only one interven-
tion sought to improve CR referral by GPs [32]. This is a
matter of concern, especially since studies reported low
referral rates [35, 37] and a strong relationship between
referral and attendance [36]. Since studies highlighted
that female [35], elderly, and single [37], patients are less
likely to be referred to CR, interventions that focus on
the needs of these special populations are indicated. In
addition, since an educational intervention was found to
have a significant positive impact on GP referral to CR
and to creation of ACS management plans [32], the
wider implementation of this quality improvement ini-
tiative has the potential to improve outcomes. Johnson
and colleagues strongly recommended that non-referred
patients be identified by their GP and be referred to CR
and those who were referred but did not attend be iden-
tified and encouraged to participate in an alternative
home-based CR program [42].
Although Fernandez et al. [38] clearly highlighted the
need for psychological management of patients with ACS,
there is little consensus or study of psychological assess-
ment in primary care. Two descriptive studies found a
complete lack of intervention [29] and inconsistent beliefs
regarding depression screening in the primary care setting
[39], highlighting an urgent need for more research to en-
hance primary care psychological management of coron-
ary disease. Both studies also used small sample sizes, so
research studying psychological assessment on a larger
scale would be advantageous. The single randomised con-
trolled trial that examined depression management found
that a telephone consultation with a psychiatrist was ef-
fective [41], suggesting that larger scale implementation of
this practice in primary care could be effective.
In studies where lifestyle management was studied, the
possession of multiple modifiable risk factors post-ACS
patients was common [33, 34, 38], while GP advice or
intervention regarding these risk factors was inconsistent
[27, 42] and sometimes severely lacking [40]. One prom-
ising interventional study found success in increasing
GP interventions regarding smoking cessation post-ACS
[30], but the success of these interventions in actually
causing patients to quit smoking is still unclear. A quali-
tative study highlighted the complexity of GP involve-
ment in smoking cessation [43], as advice regarding
smoking cessation was not always regarded positively,
and opinions were inconsistent regarding the productiv-
ity of such advice.
Hypercholesterolaemia management through modified
diet advice and LLT was generally lacking [38, 42]. In
addition, though body mass index (BMI) was not widely
addressed, two studies reported alarming rates of obese
and overweight post-ACS patients [29, 38], while advice
from GPs regarding physical activity was imperfect [42].
Little is known about GP management and advice re-
garding alcohol intake in the context of post-ACS care.
Besides depression management and a single study of a
diabetic cohort, included publications failed to address
in detail the complexities of handling ACS patients with
other relevant comorbidities. Research in this area would
assist a GP in adequately managing such complex cases.
Surprisingly, there were few studies for whom the
provision and effectiveness of lifestyle management advice
was assessed, and these had small sample sizes. Concerns
regarding the efficacy of GP advice in risk factor modifica-
tion have the potential to influence the rate at which GPs
deliver such advice, and so the development of robust
strategy regarding GP advice to reduce patient possession
of modifiable risk factors would be beneficial. This is an
area where practice nurses with chronic disease expertise
and ancillary allied health practitioners working within a
general practice setting could offer opportunities for im-
proved patient advice and outcomes.
Wai et al. [20] highlighted a need for increased com-
munication between hospitals and GPs post-ACS. A sub-
sequent quality intervention across the continuum of
care was promising [32], and has the potential to im-
prove multiple areas of evidence-based management of
post-ACS care.
Special populations
While Indigenous populations are identifiable as col-
lectively having poorer health status in Australia and
New Zealand [45], no published studies focused exclu-
sively on the primary care management of Indigenous
populations that have suffered an ACS. This is despite
documentation that Indigenous populations of both na-
tions face a disproportionate cardiovascular disease
burden and experience culture-specific barriers to care
[46]. Besides Indigenous populations, no Australian
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studies examined post-discharge ACS management in
any non-Indigenous minority populations, although
these groups were better addressed in publications from
New Zealand [20, 28, 32]. Rural populations face
unique barriers to care, and yet only five studies exam-
ined different aspects of patient care and follow-up in
this setting. This is noteworthy because a significant
portion of both Australia and New Zealand’s popula-
tions reside in rural areas. In addition, while many in-
cluded studies reported patient populations that were
overwhelmingly male, there was limited analysis of
gender-based differences in primary care management
of ACS. This is significant because post-ACS care deci-
sions have historically been gendered. Overall, though
age- and gender-related data was consistently collected,
limited analysis of this data was reported. Overwhelm-
ingly, studies followed patients from hospital rather
than focusing on GP care. Published literature was also
lacking in qualitative data, which could expose under-
lying attitudes and beliefs that affect patient care.
Study quality
Out of 17 unique studies, 13 received MMAT scores ≥
75 %, indicating that studies were of generally good
quality. No study received a score below 50 %, though
the MMAT score of one study [39] could not be
assessed, since its study protocol was not fully reported.
Strengths and limitations
This review highlights the challenges of and potential
opportunities for improvement in post-ACS manage-
ment in primary care in Australia and New Zealand. As
ACS management, as specified by the NHFA and the
CSANZ [5] and supplemented by the Cardiovascular
Therapeutic Guidelines [6], covers such a broad range of
treatment and care, this study is unique reporting on the
status of primary care management and research in this
area. This review is strengthened by its thorough litera-
ture search of multiple databases, and by the quality ap-
praisal of publications in the MMAT format.
Several factors limit the definitive conclusions that can
be drawn from the review. In the literature selection
process, the possibility exists that relevant article(s) were
not identified by the literature search because of gaps in
implemented database search strings, although search
strings for each database were developed with careful
consideration and input from multiple authors, they
were not proofread by any third-party assistant or librar-
ian. The decision to limit this review to peer-reviewed
publications additionally creates the potential of publica-
tion bias [47], especially since studies of populations
often neglected by peer-reviewed publications, like Indi-
genous or rural populations, may be conducted by
organisations that lack the financial means to publish
academically.
The mixed-methods nature of the publications ob-
tained from the literature search limited the nature of
analysis. A meta-analysis was impossible, because of the
inclusion of studies that were qualitative, descriptive,
and non-interventional. In addition, studies were often
limited in the amount of data that was publicly available:
studies sometimes only published significant findings or
short reports rather than exhaustive research papers.
This data limitation was further complicated by the fact
that the aim or research question of included studies
often differed drastically from the aim of this review
(Table 4). The number of publications also restricted the
ability to draw conclusions about areas for improve-
ments across the continuum of care. Studies that de-
scribe successful interventions may not apply in special
population groups, but since special populations were
largely not addressed, it is difficult to determine the suc-
cess of interventions for them. The limited number of
publications suggests that more follow-up data or re-
search in this area is required.
The coverage of the subject matter of these publica-
tions was also restricted in regard to barriers and facili-
tators to primary care management of ACS, because the
studies do not include patients that were prevented by
some means from accessing a GP in the first place.
Conclusions
Primary care management of post-ACS patients is
proven to increase the quality of patients’ lives, and
reduce their risk of a secondary cardiac event and
healthcare system costs of rehospitalisation. Under-
standing management in primary care and identifying
gaps is essential to improving the quality of care for a
common, serious, cardiovascular condition where un-
necessary readmissions can be avoided. Given high
rates of CVD, relatively few papers were identified re-
garding management in primary health care settings
after an acute coronary syndrome event. This is sur-
prising given the importance of support for patients
at this time, specifically around adherence to evidence
based medications and adopting a healthy lifestyle in
order to reduce the chances of a recurrence. There
were few interventional studies, so further research of
ways to improve quality of care is clearly indicated.
Future study should include efforts to improve the
quality of care of special population groups must be
customised to their particular needs [46]. It is clear
that greater integration of hospital and GP manage-
ment in the form of detailed discharge summaries
and communication of management plans would
allow for more effective patient care.
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